Advertisement
U.S. markets open in 1 hour 10 minutes

Amneal Pharmaceuticals, Inc. (AMRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
8.47-0.11 (-1.28%)
At close: 04:00PM EDT
8.62 +0.15 (+1.77%)
After hours: 05:51PM EDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
2,597,992
2,393,607
2,212,304
2,093,669
1,992,523
-
Cost of Revenue
1,687,627
1,573,042
1,427,596
1,324,696
1,364,130
-
Gross Profit
910,365
820,565
784,708
768,973
628,393
-
Operating Expense
631,503
596,315
595,786
575,067
517,312
-
Operating Income
278,862
224,250
188,922
193,906
111,081
-
Net Non Operating Interest Income Expense
-282,684
-251,434
-158,668
-136,325
-145,998
-
Other Income Expense
-111,799
-13,086
-278,381
-26,215
-863
-
Pretax Income
-115,621
-40,270
-248,127
31,366
-35,780
-
Tax Provision
17,581
8,452
6,662
11,196
-104,358
-
Net Income Common Stockholders
-174,616
-83,993
-129,986
10,624
91,059
-
Diluted NI Available to Com Stockholders
-174,616
-83,993
-129,986
10,624
91,059
-
Basic EPS
0.07
-0.48
-0.86
0.07
0.62
-
Diluted EPS
0.06
-0.48
-0.86
0.07
0.61
-
Basic Average Shares
152,893
176,136
150,944
148,922
147,443
-
Diluted Average Shares
155,083
176,136
150,944
151,821
148,913
-
Total Operating Income as Reported
174,565
204,374
-94,928
152,716
91,155
-
Total Expenses
2,319,130
2,169,357
2,023,382
1,899,763
1,881,442
-
Net Income from Continuing & Discontinued Operation
-174,616
-83,993
-129,986
10,624
91,059
-
Normalized Income
-79,367
-69,611
104,023
37,337
93,580
-
Interest Expense
241,879
210,629
158,377
136,325
145,998
-
Net Interest Income
-282,684
-251,434
-158,668
-136,325
-145,998
-
EBIT
126,258
170,359
-89,750
167,691
110,218
-
EBITDA
351,497
399,759
150,425
401,097
345,605
-
Reconciled Cost of Revenue
1,687,627
1,573,042
1,427,596
1,324,696
1,364,130
-
Reconciled Depreciation
225,239
229,400
240,175
233,406
235,387
-
Net Income from Continuing Operation Net Minority Interest
-174,616
-83,993
-129,986
10,624
91,059
-
Total Unusual Items Excluding Goodwill
-120,568
-18,205
-296,214
-41,545
-3,453
-
Total Unusual Items
-120,568
-18,205
-296,214
-41,545
-3,453
-
Normalized EBITDA
472,065
417,964
446,639
442,642
349,058
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
-25,319
-3,823
-62,205
-14,832
-932.31
-